| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
|
|
|
|
|||||||||||||
|
|
|||||||||||||||
ORIGINAL ARTICLE |
1 Division of Neonatology, Catholic University of the Sacred Heart, Rome, Italy
2 Division of Child Neurology, Catholic University of the Sacred Heart
Correspondence to:
Correspondence to:
Dr Romagnoli, Division of Neonatology, Catholic University of the Sacred Heart, Largo A Gemelli 8, 00168 Rome, Italy;
cromagnoli{at}rm.unicatt.it
Objective: To assess the effect of moderately early postnatal dexamethasone treatment on growth and neurodevelopmental outcome in preterm infants.
Methods: Thirty preterm infants enrolled in a randomised clinical trial to investigate the effectiveness of moderately early dexamethasone administration in the treatment of chronic lung disease were routinely followed up. Fifteen babies received a total dose of 4.75 mg/kg over 14 days from the 10th day of life, and 15 babies were untreated. Five infants in each group received open label steroids to facilitate extubation later in their clinical course. Growth and neurodevelopmental outcome are reported.
Results: The mean body weight, height, and head circumference as well as the number of babies with anthropometric measurements within normal range were similar in treated and untreated babies. There was no significant difference between treated and control groups with respect to incidence of cerebral palsy, major neurosensory impairment, mean intelligence quotient scores, and behavioural abnormalities.
Conclusions: Postnatal dexamethasone treatment with the schedule used in this study did not impair growth and neurodevelopmental outcome in preterm infants. Data from larger trials have raised major concern that postnatal steroid treatment may increase neurodevelopmental impairment. The full extent of the risk will only be known when more trials have reported follow up data.
Keywords: chronic lung disease; postnatal steroids; dexamethasone
Relevant Article
Arch. Dis. Child. Fetal Neonatal Ed. 2002 87: F2.
This article has been cited by other articles:
|
|
 |
|
  J. L. Y. Cheong, R. W. Hunt, P. J. Anderson, K. Howard, D. K. Thompson, H. X. Wang, M. J. Bear, T. E. Inder, and L. W. Doyle Head Growth in Preterm Infants: Correlation With Magnetic Resonance Imaging and Neurodevelopmental Outcome Pediatrics, June 1, 2008; 121(6): e1534 - e1540. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. W. Doyle, H. L. Halliday, R. A. Ehrenkranz, P. G. Davis, and J. C. Sinclair Impact of Postnatal Systemic Corticosteroids on Mortality and Cerebral Palsy in Preterm Infants: Effect Modification by Risk for Chronic Lung Disease Pediatrics, March 1, 2005; 115(3): 655 - 661. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. R. Neal Jr., G. Weidemann, M. Kabbaj, and D. M. Vazquez Effect of neonatal dexamethasone exposure on growth and neurological development in the adult rat Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2004; 287(2): R375 - R385. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. F. Yeh, Y. J. Lin, H. C. Lin, C. C. Huang, W. S. Hsieh, C. H. Lin, and C. H. Tsai Outcomes at School Age after Postnatal Dexamethasone Therapy for Lung Disease of Prematurity N. Engl. J. Med., March 25, 2004; 350(13): 1304 - 1313. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O Baud Postnatal steroid treatment and brain development Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2004; 89(2): F96 - F100. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
| ARCH DIS CHILD | FETAL NEONATAL ED | ED PRACTICE |
